J&J expects cancer drugs, medical devices to drive growth in 2023
...(Reuters) -Johnson & Johnson forecast 2023 profit above Wall Street......…
159,530$
-0,67%
Echtzeit-Aktienkurs Johnson & Johnson
Bid:
Ask:
Nachrichten zur Johnson & Johnson Aktie
Form 8-K JOHNSON & JOHNSON For: Jul 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J-spinoff Kenvue forecasts upbeat annual profit on strong self-care demand
...(Reuters) -Kenvue, the former consumer health unit of Johnson......…
Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson Q2 Profit Increases, beats estimates
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced earnings for its second quarter that increased from last year and…
UPDATE 2-J&J expects cancer drugs, medical devices to drive growth in 2023
... in
paragraph 12)
July 20 (Reuters) - Johnson & Johnson forecast
2023 profit above......…
Johnson & Johnson’s stock up 2.4% premarket after earnings top estimates and company raises guidance
Johnson & Johnson’s stock JNJ rose 2.4% in premarket trade Thursday, after the health care company posted better-than-expected second-quarter earnings…
Johnson & Johnson Earnings Top Forecasts On Solid Medical Device Sales; Kenvue Exchange Offer Planned
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
The results come amid investor anxiety over the thousands of lawsuits claiming that J&Js talc-based baby powder and other products…
Stocks Mixed, Tesla Muted, Netflix Slumps, Johnson & Johnson On Deck, United Airlines Lift-Off - 5 Things To Know
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson, Tesla And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today…
Johnson & Johnson Prepares for Earnings. Talc Worries Are Top of Mind for Investors.
The company is slated to report its financial results for the second quarter on Thursday....…
Johnson & Johnson Sues HHS Over Medicare Drug Price Negotiation Program
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (J&J) has filed a lawsuit against the Department of Health and Human Services…
Johnson & Johnson must pay $18.8m to cancer patient in baby powder lawsuit
Jury rules in favor of California man who says he developed a deadly cancer from heavy exposure to talc powder…
Johnson & Johnson Prepares for Earnings. Talc Worrries Are Top of Mind for Investors.
The company is slated to report its financial results for the second quarter on Thursday....…
Babypuder: Johnson & Johnson muss Krebspatient 18,8 Millionen US-Dollar zahlen
Ein 24-Jähriger erkrankt an Krebs und wähnt mutmaßlich belastetes Babypuder als Ursache. Hersteller J&J hält dagegen – nun entschied ein…
J&J ordered to pay $18.8M over baby powder cancer claim, jury rules
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
UPDATE 1-J&J must pay $18.8 mln to California cancer patient in baby powder suit
...(Adds background on case)
By Brendan Pierson
July 18 (Reuters....
Reuters watched the trial through Courtroom View Network.
J&J has denied......…
J&J must pay $18.8 million to California cancer patient in baby powder suit
...By Brendan Pierson
(Reuters) - Johnson & Johnsons must pay $18.8......…
J&J must pay $18.8 mln to California cancer patient in baby powder suit
...By Brendan Pierson
July 18 (Reuters) - Johnson & Johnsons must pay......…
Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program
Johnson & Johnson JNJ has joined companies such as Merck & Co. Inc. MRK, Bristol Myers Squibb Co. BMY and…
J&J becomes latest Big Pharma to sue over Medicare drug pricing
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector
Growth in J&Js (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment,…
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month....…
J&J sues US govt to halt Medicare drug price negotiation plans
...(Reuters) - Johnson & Johnson sued the U.S. government on Tuesday......…
UPDATE 1-J&J sues US govt to halt Medicare drug price negotiation plans
...(Adds background throughout)
July 18 (Reuters) - Johnson & Johnson......…
Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson Poised For A Muted Q2?
We expect the companys revenues to come in at $24.6 billion, marginally below the consensus estimate of $24.7 billion....…
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products....…
Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries
The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop…
Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth
Johnson & Johnson (JNJ) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…
Is Johnson & Johnson Stock Overvalued?
The stocks premium valuation could be justified....…
FDA classifies J&J electrode recall as most serious type
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Jurors urged to impose heavy punitive damages in J&J talc trial
...By Brendan Pierson
July 10 (Reuters) - Lawyers for a California man......…
Johnson & Johnson 2Q financial results could beat even as pharma sales weigh
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Johnson & Johnson 2Q results could beat even as pharma sales weigh
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX
Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX...…
NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3
PARIS and CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…
Is Johnson & Johnson Stock a Buy Now?
Some businesses never go out of style....…
Is Johnson & Johnson Stock a Buy?
Lets take a look at this Dividend King after its spin-off of Kenvue and its proposed $8.7 billion litigation settlement....…
J&J strebt Bewertung von bis zu 43 Milliarden für Verbrauchergeschäft an
Frankfurt (Reuters) - Der US-Pharmakonzern Johnson & Johnson strebt beim geplanten Börsengang seines Geschäfts mit rezeptfreien Gesundheitsprodukten eine Bewertung von…
Johnson & Johnson hebt Jahresziele an - Quartalsverlust nach Milliardenvergleich
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Konsumgüterkonzern Johnson & Johnson ist besser als erwartet…
J&J-Tochterfirma beantragt erneut Gläubigerschutz im Babypuder-Skandal
New York (Reuters) - Eine Tochterfirma des US-Pharma- und Konsumgüterherstellers Johnson & Johnson (J&J) hat im Skandal um mutmaßlich asbestverseuchtes…
Johnson & Johnson will 'Baby Powder'-Klagen mit Milliarden-Vergleich beilegen
NEW BRUNSWICK (dpa-AFX) - Der US-Pharmakonzern Johnson & Johnson (J&J) will einen großen Rechtsstreit um…
Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…
Johnson & Johnson verfehlt 2022 eigene Wachstumsziele
NEW BRUNSWICK (dpa-AFX) - Weniger verkaufte Covid-Impfungen und der starke Dollar haben den Pharma- und Konsumgüterkonzern…
Johnson & Johnson: Aussichtsreicher HIV-Impfstoff schützt nicht
BERLIN (dpa-AFX) - Ein besonders aussichtsreicher Impfstoffkandidat gegen die Immunschwächekrankheit Aids schützt nicht ausreichend vor einer…
Johnson&Johnson-Sparte Kenvue stellt Antrag auf Börsennotierung
Bangalore (Reuters) - Die Consumer-Health-Sparte mit rezeptfreien Medikamenten und anderen Gesundheitsprodukten des US-Pharmakonzerns Johnson & Johnson (J&J) hat einen Antrag…
Gesundheitskonzern Johnson & Jonson spürt Gegenwind durch starken Dollar
NEW BRUNSWICK (dpa-AFX) - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson…
US-Gesundheitskonzern Johnson & Johnson senkt wegen Dollarstärke Prognose
NEW BRUNSWICK (dpa-AFX) - Der starke Dollar bremst den Gesundheitskonzern Johnson & Johnson . Für das…